Completed PHASE1 INTERVENTIONAL 2-arm NCT01241903

Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions

Early Use of Rosuvastatin (Crestor) in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions

Sponsor: Susan Smyth

Conditions Acute Coronary Syndrome Angioplasty, Transluminal, Percutaneous Coronary Blood Platelets Hydroxymethylglutaryl-CoA Reductase Inhibitors

Interventions placebo rosuvastatin

Updated 9 times since 2017 Last updated: Feb 26, 2017 Started: Jun 30, 2011 Primary completion: Aug 31, 2013 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01241903, this PHASE1 trial focuses on Acute Coronary Syndrome and Angioplasty, Transluminal, Percutaneous Coronary and remains completed. Sponsored by Susan Smyth, it has been updated 9 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1
Jan 2021 — Dec 2022 [monthly]

Completed PHASE1

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
May 2017 — Jun 2018 [monthly]

Completed PHASE1
Feb 2017 — May 2017 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Susan Smyth

Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lexington, United States